Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1

Journal of Medical Genetics

Volumn 43, Issue 10, 2006, Pages 810-813

  Lammert, M ^a   Friedman, J M ^b,f   Roth, H J ^c   Friedrich, R E ^a   Kluwe, L ^a   Atkins, D ^d   Schooler, T ^e   Mautner, V F ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Limbach Laboratory   (Germany)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SEX RATIO; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; CAFE-AU-LAIT SPOTS; CALCIFEDIOL; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROFIBROMATOSES; NEUROFIBROMATOSIS 1; SKIN NEOPLASMS; VITAMIN D DEFICIENCY;

EID: 33750435875     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2006.041095     Document Type: Article

References (27)

1. Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O'Connell P, White R. A major segment of neurofibramatosis type 1 gene: cDNA sequence, genomic structure and point mutations. Cell 1990;62:193-201.
2. Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA, White R, O'Connell P. Deletions and translocations interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990;62:187-92.
3. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990;249:181-6.
4. Huson S. Neurofibromatosis 1: a clinical and genetical overview. In Huson S, Hughes R, eds. The neurofibromotoses:a pathogenetic and clinical overview. London Chapman and Hall Medical, 1994:160-203.
5. Friedman JM, Gutmann DH, MacCollin M, Riccardi VM, eds. Neurofibromatosis: phenotype, natural history, and pathogenesis. Baltimore: Johns Hopkins University Press, 1999.
6. Szudek J, Birch P, Friedman J. Growth in North American white children with neurofibromatosis 1 (NF1). J Med Genet 2000;37:933-8.
7. Illes T, Halmai V, de Jonge T, Dubousset J. Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporosis Int 2001;12:823-7.
8. Brunetti-Pierri N, Phan K, Carter S, Lewis RA, Plon S, Ellis KJ, O'Brian SE, Lee B. Generalized osteopenia in neurofibromatosis type 1 patients points to an underlying disorder or skeletal homeostasis and mineralization. Am J Hum Genet, 2003;73(suppl):s261.
9. Kuorilehto T, Poyhonen M, Bloigu R, Heikkinen J, Vaananen K, Peltonen J. Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int 2004;16:928-36.
10. Lammert M, Kappler M, Mautner VF, Lammert K, Storkel S, Friedman JM, Atkins D. Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int 2005;16:1161-6.
11. Holick M. Sunlight and vitamin D for bone health and prevention of autoimmune disease, cancers and cardiovascular disease. Am J Clin Nutr 2004;80(suppl):1678-885.
12. Konishi K, Nakamura M, Yamakawa H, Suzuki H, Saruta T, Honaoka H, Davatchi F. Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis. Am J Med Sci 1991;301:322-8.
13. Nakayama J, Kiryu H, Urabe K, Matsuo S, Shibata S, Koga T, Furue M. Vitamin D3 analogues improve cafe au lait spots in patients with von Recklinghausen's disease: experimental and clinical studies. Eur J Dermatol 1999;9:202-6.
14. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51-7.
15. Calvo M, Whiting S. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev 2003;61:107-13.
16. Holick MF. Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J 2005;98:1024-7.
17. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002;39:311-14.
18. Zoller M, Rembeck B, Akesson HO, Angervall L. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, Sweden. Acta Derm Venereol 1995;75:136-40.
19. Rasmussen S, Yang Q, Friedman J. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 2001;68:1110-18.
20. Tonsgard JH, Kwak SM, Short MP, Dachman AH. CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions. Neurology 1998;50:1755-60.
21. Thakkar S, Feigen U, Mautner V. Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety. Neuroradiology 1999;41:625-9.
22. Cichowski K, Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001;104:593-604.
23. Dasgupta B, Gutmann D. Neurofibromatosis 1: closing the GAP between mice and men. Curr Opin Genet Dev 2003;13:20-7.
24. Kuorilehto T, Nissinen M, Koivunen J, Benson MD, Peltonen J. NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos. J Bone Miner Res 2004;19:983-9.
25. Yu X, Chen S, Potter OL, Murthy SM, Li J, Pulcini JM, Ohashi N, Winata T, Everett ET, Ingram D, Clapp WD, Hock JM. Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Bone 2005;36:793-802.
26. Goltzman D, White J, Kremer R. Studies of the effects of 1,25-dihydroxyvitamin D on skeletal and calcium homeostasis and on inhibition of tumor cell growth. J Steroid Biochem Mol Biol 2001;76:43-7.
27. Dusso A, Brown A, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005;289:F8-28.